Log in
Enquire now
AN2

AN2

AN2 is a novel medicines targeting infectious diseases founded by Eric Easom.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
‌
Eric Easom
0
Legal Name
AN2 Therapeutics, Inc.
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@an2therapeutics.com
Founder
‌
Eric Easom
0
Full Address
1800 El Camino Real, Suite D Menlo Park, CA 94027, USA
Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Investors
Hatteras Venture Partners
Hatteras Venture Partners
BioRock Ventures
BioRock Ventures
Adjuvant Capital
Adjuvant Capital
Brii Biosciences
Brii Biosciences
Surveyor Capital
Surveyor Capital
RA Capital Management
RA Capital Management
Latest Funding Round Date
January 7, 2022
Latest Funding Round Amount (USD)
80,000,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/an2-therapeutics-inc
Location
San Francisco
San Francisco
Menlo Park, California
Menlo Park, California
Number of Employees (Ranges)
11 – 50
Phone Number
+16503319090
Pitchbook URL
pitchbook.com/profiles...343121-05
Exchange
Nasdaq
Nasdaq
Ticker Symbol
ANTX
Total Funding Amount (USD)
92,000,000
Twitter URL
@AN2Therapeutics
Official Website
an2therapeutics.com

Find more companies like AN2

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.